Toxic Exposure: Key Strategies Explained in a Clinical Approach

Understanding a clinical approach to toxic exposure is crucial for improving health outcomes and prevention strategies.

Abstract

In this educational post, I, Dr. Alex Jimenez, will guide you on a comprehensive, clinically grounded journey through the complex world of acute toxicology. Drawing on my diverse background in chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP, ATN, CCST), I will bridge the gap between emergency interventions and holistic, long-term recovery. We will explore the latest findings from leading researchers, presenting them through the lens of modern, evidence-based practices. This post deconstructs core toxidromes, antidote strategies, and the physiological mechanisms behind common poisonings, including those from salicylates (aspirin), acetaminophen, toxic alcohols (ethylene glycol, methanol), carbon monoxide, cyanide, and various cardiovascular medications. We will also delve into specific management protocols for conditions like serotonin syndrome, organophosphate poisoning, and sympathomimetic crises.

A central theme is our unique collaborative model at Injury Medical Clinic PA in El Paso, Texas. I will explain how my work in chiropractic, functional medicine, and rehabilitation is seamlessly integrated with the profound medical expertise of our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is a board-certified internist with over 40 years of invaluable experience (NPI #1164426749, Texas MD License #J2933), providing the essential medical oversight that defines our multidisciplinary approach. Together, we manage complex cases, including personal injuries and toxic exposures, ensuring a continuum of care that addresses both acute symptoms and the underlying physiological imbalances to restore long-term health. You will learn practical, step-by-step protocols for various toxic emergencies and understand how integrative chiropractic care supports hemodynamic stability, autonomic recalibration, pain modulation, and full-body rehabilitation.

Our Integrated Care Philosophy: A Synergy of Disciplines

At Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, here in El Paso, Texas, we have cultivated a clinical environment where different medical disciplines converge to provide patient-centered care. I, Dr. Alex Jimenez, bring a multifaceted background as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), Board-Certified Family Nurse Practitioner (FNP-BC), Certified Functional Medicine Practitioner (CFMP), and an Institute for Functional Medicine Certified Practitioner (IFMCP). This diverse training allows me to view patient health through a holistic lens, connecting the dots between structural integrity, neurological function, and biochemical balance.

The medical directorship of Dr. Maria Guadalupe Cardenas, MD, powerfully complements this approach. With h r extensive four-decade career in internal medicine, Dr. Cardenas provides the foundational medical oversight that is paramount in a multidisciplinary setting. This step is common in leading-edge integrative and injury care clinics, where a medical doctor provides essential oversight and direction for patient care. She guides our medical protocols, manages complex internal medicine aspects of our patients’ conditions, and collaborates directly with our team on diagnosis and treatment planning. This collaborative framework is especially vital when we encounter patients who have sustained injuries in accidents, which often involve not just musculoskeletal trauma but also potential toxic exposures.

How Our Team Works Together

Our collaborative approach ensures that every patient benefits from a comprehensive diagnostic and treatment strategy. Here’s how we integrate our services:

• Medical Oversight (Dr. Cardenas): Cardenas provides the critical medical framework for our practice. She coordinates toxicology triage, diagnostics, medication management, and acute medical interventions, ensuring alignment with current emergency and internal medicine standards. Her role is indispensable when patients present with conditions that have systemic implications, such as the toxicological scenarios we will discuss.
• Integrative Chiropractic and Functional Medicine (Dr. Jimenez): My role focuses on the body’s innate ability to heal. Through chiropractic care, I address spinal misalignments (subluxations) that can interfere with the nervous system, which is the master controller of all bodily functions. This is particularly relevant in recovery from a toxic event, where the nervous system has been under immense stress. My functional medicine practice involves a deep dive into the patient’s biochemistry, identifying and addressing root causes of dysfunction through advanced lab testing, nutritional therapy, and lifestyle modification.
• Synergistic Patient Care: When a patient comes to our clinic, especially after a personal injury that may involve medication management or exposure to toxins, our team works in concert. Dr. Ca denas might manage the pharmacological aspects and acute medical needs, while I focus on structural rehabilitation, neurological optimization, and metabolic support. This ensures that we are not just treating symptoms but restoring the patient’s overall health and resilience.
• Unified Care Pathways: We implement shared protocols for toxic ingestions and exposures, coordinate post-ICU or post-ED transitions, and monitor for delayed complications. Many toxic exposures intersect with injury events (industrial, environmental, vehicular), so our care plans incorporate pain control, functional restoration, return-to-work guidelines, and medico-legal documentation when appropriate.

This synergy ensures that when a patient presents with symptoms that could stem from a toxic exposure, we are equipped to manage the acute medical needs while simultaneously planning for the long-term neurological, musculoskeletal, and metabolic recovery.

Core Principles: The Foundation of Toxicology Management

In toxic emergencies, the fundamentals never change: secure airway, support breathing, stabilize circulation. Every decision flows from these priorities, then expands into receptor-level, metabolic, and pharmacokinetic reasoning.

When I am faced with any patient in an emergency scenario, my training as a nurse practitioner and chiropractor has ingrained in me the importance of a systematic approach. The priority is always the ABCs: Airway, Breathing, and Circulation.

The Intubation Dilemma in the Hyperventilating Patient

In the context of a toxicological emergency, there is a significant caveat to consider, particularly when it comes to airway management. Let’s imagine a patient who has overdosed on a substance like aspirin. They are profoundly altered, and I determine that I must take control of their airway to protect it. The impulse is to intubate. But we must remember how they presented. They were likely tachypneic, breathing very rapidly. This hyperventilation is not a random symptom; it is a vital part of their body’s compensatory mechanism.

The overdose has plunged their body into a severe metabolic acidosis. To counteract the plummeting pH of their blood, the body’s respiratory center goes into overdrive, attempting to blow off as much carbon dioxide (CO2) as possible. Since  O2 forms carbonic acid in the blood, reducing CO2 levels helps to raise the pH back toward normal. This is a life-saving compensation.

Here lies the danger of routine intubation. If I intubate this patient, who was breathing at a rate of 50 times per minute, and set the ventilator to a standard rate of, say, 12 breaths per minute, I have just eliminated their primary defense mechanism. Their  O2 levels will rapidly climb back to a “normal” range, but in the face of their underlying metabolic acidosis, this normalization is catastrophic. Their blood pH will plummet, they will go into cardiac arrest, and they will die.

For this reason, we try to avoid intubating these patients whenever possible. If intubation is necessary because of a failing airway or profound obtundation, I must match their pre-intubation respiratory rate on the ventilator. This means setting the ventilator to a very high rate to continue the compensatory hyperventilation. Furthermore, we try not to use long-acting paralytics. If we ust paralyze them for the procedure, we must ensure that the hyperventilation is maintained without interruption until the underlying acidosis can be treated. This principle is not unique to aspirin; it is equally critical for patients in Diabetic Ketoacidosis (DKA), another classic state of metabolic acidosis where compensatory hyperventilation is key to survival.

Beyond the ABCs: Essential First Steps

• Rapid Glucose Check: I always check a glucose level immediately. Hypoglycemia can mimic or complicate any toxidrome. Certain toxins impair insulin release or cellular glucose utilization. We must treat hypoglycemia immediately if present.
• First-Line Calming and Seizure Control: Benzodiazepines are my universal first-line agents for managing hyperadrenergic states, agitation, psychosis, seizures, hyperthermia, and hypertensive surges. Midazolam is my preferred agent due to its rapid onset, reliable IM/IV/IN delivery, and predictable titration.
• Differential Diagnosis in Altered Mental Status: In acute care, when I confront a patient with altered mental status, I widen my differential diagnosis beyond toxicology to include:

• • Postictal state
  • Sepsis
  • Hypoglycemia
  • Trauma
  • Electrolyte abnormalities
  • CNS events (stroke, hemorrhage)
  • Toxins and medications

• Decontamination:

• • Skin/Ocular Decontamination: This is essential when patients present with visible contamination or suspected dermal absorption risks (e.g., organophosphates). Copious water irrigation is generally safe and effective after removing contaminated clothing.
  • Personal Protective Equipment (PPE): PPE for staff is mandatory with suspected organophosphate or similar agents to prevent secondary contamination.

Toxidromes: Pattern Recognition to Accelerate Life-Saving Decisions

Why do toxidromes matter? Because clustered signs and symptoms guide antidote selection and prevent critical time loss. By assessing the patient’s clinical findings—their pupils, skin moisture, mental status, vital signs, GI secretions, and EKG patterns—we can group symptoms to help narrow down the potential class of substance involved. This can guide initial workup and treatment even before specific lab results are available.

• Anticholinergic:

• • Findings: “Hot as a hare, blind as a bat, dry as a bone, red as a beet, mad as a hatter.” This translates to mydriasis (dilated pupils), hot and dry skin, hyperthermia, delirium/psychosis, tachycardia, urinary retention, and decreased bowel sounds. Seizures can also occur.
  • Causes: Antihistamines (e.g., diphenhydramine), tricyclic antidepressants (TCAs), antipsychotics, antiparkinsonian agents, atropine, and plant alkaloids (e.g., deadly nightshade).
  • Risks: Sodium channel blockade with TCAs, leading to a wide QRS on the EKG.

• Cholinergic:

• • Findings: The mnemonic SLUDGE (Salivation, Lacrimation, Urination, Defecation, GI cramps, Emesis) captures the muscarinic effects. Other signs include bronchorrhea/bronchospasm, bradycardia, and miosis (pinpoint pupils). Nicotinic effects include muscle weakness and paralysis.
  • Causes: Organophosphates, carbamates, and nerve agents.
  • Risks: Rapid airway compromise from flooding secretions and diaphragmatic failure.

• Sympathomimetic:

• • Findings: Mydriasis, diaphoresis (hot and wet skin), agitation/psychosis, tachycardia, hypertension, hyperthermia, tremors, and seizures.
  • Causes: Cocaine, methamphetamine, amphetamines, and synthetic cathinones (“bath salts”).
  • Risks: Coronary vasospasm, myocardial infarction, rhabdomyolysis, DIC, and stroke.

• Opioid:

• • Findings: The classic triad is CNS depression, respiratory depression, and miosis. However, pupils are not always constricted. Bradycardia and hypotension are also common.
  • Antidote: Naloxone, with careful titration.

• Sedative-Hypnotic:

• • Findings: CNS depression and ataxia, typically with normal pupils and mild hypotension. Respiratory depression is less pronounced than with opioids unless co-ingested with other depressants like alcohol.
  • Caution: We generally avoid the reversal agent flumazenil in unknown overdoses due to the high risk of precipitating intractable seizures in chronic benzodiazepine users.

The Role of Chiropractic Integration Post-Toxidrome

Survivors of severe toxidromes often suffer from prolonged autonomic dysfunction, sleep disruption, and musculoskeletal sequelae. In my clinical observations, I consistently see how toxicologic stressors amplify pain perception, muscular guarding, and autonomic reactivity, delaying recovery after trauma (Jimenez, n.d.-a; Jimenez, n.d.-b). Post-stabilization, our integrative approach becomes critical. Spinal manipulation, soft tissue therapies, and graded exercise can lower sympathetic arousal, improve sleep patterns, and reduce pain amplification, enabling an earlier return to function. The timing and intensity of these interventions are always coordinated with medical parameters set by Dr. Cardenas to ensure patient safety.

Gastrointestinal Decontamination: When and How

Once we have stabilized the patient, we consider if we can prevent further absorption of the toxin from the GI tract. The options have evolved significantly over the years.

• Induced Emesis: This is obsolete due to high aspiration risk and poor evidence of benefit.
• Gastric Lavage: This is rarely indicated. It may be useful only in select, early (within 1-2 hours), life-threatening ingestions where the patient’s airway is protected.
• Activated Charcoal: This can be given within approximately 4 hours of ingestion to reduce absorption for many substances. It acts like a sponge, binding the toxin in the gut. However, it is contraindicated if the airway is unprotected (risk of aspiration pneumonitis) or if the substance is not adsorbed by charcoal (e.g., heavy metals, alcohols, caustics, iron, lithium).
• Whole Bowel Irrigation (WBI): This is reserved for specific situations. We administer a large volume of a polyethylene glycol solution (the same used for colonoscopy prep) to flush the entire GI tract. WBI is the indicated therapy for:

• • Sustained-release or enteric-coated drugs.
  • Body packers/stuffers with intact packets of illicit drugs.
  • Ingestions of substances poorly adsorbed by charcoal, such as iron and lithium.

• This is performed under close monitoring, with preparedness for emergent surgical intervention if a drug packet ruptures.

Specific Toxidromes and Their Management

Anticholinergic Toxicity and Sodium Channel Blockade

Let’s consider a case pattern: a two-year-old presents with seizures, hyperthermia, tachycardia, mydriasis (dilated pupils), hot dry skin, and a wide QRS complex on their EKG. This constellation of findings screams anticholinergic toxidrome with sodium channel blockade, highly suspicious for a tricyclic antidepressant (TCA) ingestion.

The Critical Role of Sodium Bicarbonate

The wide QRS complex (>100 ms), often with a terminal R wave in lead aVR, is the EKG hallmark of sodium channel blockade. This is a life-threatening emergency. The antidote is sodium bicarbonate. Its mechanism is twofold:

1. Increases Serum Sodium: The increased sodium concentration helps to competitively overcome the toxin’s blockade of the fast sodium channels in the myocardium.
2. Alkalinizes the Serum: Raising the blood pH shifts the TCA to its non-ionized, protein-bound form. This reduces the amount of free, active drug available to bind to the sodium channels.

The protocol involves giving an initial bolus followed by a continuous infusion, targeting a serum pH of approximately 7.45–7.55 while closely monitoring electrolytes, especially potassium.

Other Key Interventions for TCA Overdose

• ABCs: Early airway protection is critical if mental status is compromised.
• Benzodiazepines: These are first-line for seizures and agitation.
• Cooling Measures: Aggressive cooling is needed for hyperthermia.
• Vasopressors: If hypotension persists despite fluids and bicarbonate, norepinephrine is the preferred agent.
• Contraindicated Medications: We must avoid physostigmine in TCA cardiotoxicity due to the risk of inducing asystole. Class  A and IC antiarrhythmics are also contraindicated as they worsen sodium channel blockade.

Organophosphate Poisoning: A Cholinergic Crisis

Organophosphate poisoning results from irreversible inhibition of the enzyme acetylcholinesterase, leading to a massive accumulation of acetylcholine and overstimulation of both muscarinic and nicotinic receptors. A critical concept is “aging,” where the bond between the organophosphate and the enzyme becomes permanent over time. This makes early treatment essential.

The SLUDGE Mnemonic and Airway Catastrophe

The clinical signature is a cholinergic crisis. Muscarinic effects are remembered by the SLUDGE mnemonic: Salivation, Lacrimation, Urination, Defecation, GI cramps, and Emesis. The most life-threatening feature is bronchorrhea—the “DUMBELS” mnemonic adds this with Bronchorrhea, Bronchospasm, and Bradycardia. The airway floods with secretions. Nicotinic effects cause muscle twitching, weakness, and eventually flaccid paralysis, including the diaphragm.

Management Priorities: Atropine and Pralidoxime

1. Decontamination: Immediately remove contaminated clothing and irrigate the skin with copious water. Staff must wear appropriate PPE.
2. Airway Management: This is paramount. Suctioning is critical, and early intubation is often necessary.
3. Atropine: This is a competitive antagonist at muscarinic receptors. We titrate atropine not to the heart rate, but to the drying of bronchial secretions. There is no absolute maximum dose in this setting; we give as much as is needed to clear the airway.
4. Pralidoxime (2-PAM): This is the specific antidote that reactivates acetylcholinesterase. It is most effective against the nicotinic effects (muscle weakness). It must be given as early as possible to be effective, before the “aging” process is complete.
5. Benzodiazepines: These are used to control seizures.

Sympathomimetic Toxicity: Cocaine and Methamphetamine

Toxicity from stimulants like cocaine and methamphetamine is caused by excess catecholaminergic activation, leading to tachycardia, hypertension, hyperthermia, agitation, and psychosis. The skin is typically hot but sweaty (diaphoretic), which helps distinguish it from the dry skin of anticholinergic toxicity.

Treatment Pillars

• Benzodiazepines: These are the cornerstone of treatment. They reduce central sympathetic outflow, controlling agitation, hypertension, tachycardia, and hyperthermia, and they are the first-line treatment for seizures.
• Cooling: Aggressive cooling is vital for hyperthermia to prevent rhabdomyolysis and organ failure.
• Avoid Pure Beta-Blockade: A critical pearl is to avoid pure beta-blockers like metoprolol for hypertension. Blocking beta-receptors leaves the alpha-receptors unopposed, which can lead to paradoxical and severe vasoconstriction, worsening hypertension and coronary ischemia. If a beta-blocker is needed, a mixed alpha/beta-blocker like labetalol is the safer choice.
• Vasodilators: For chest pain and coronary vasospasm, nitroglycerin is often used.
• Sodium Bicarbonate: Cocaine also has sodium-channel blocking properties, so we use sodium bicarbonate for a wide QRS complex, just as in TCA overdose.

Opioid Toxicity and the Challenge of Synthetics

The classic opioid toxidrome includes CNS depression, respiratory depression, and miosis. However, with the rise of ultra-potent synthetic opioids like illicitly manufactured fentanyl and its analogs, the clinical challenge has intensified.

High-Dose Naloxone Strategies

Naloxone is a competitive opioid antagonist. The management principle is to titrate naloxone to restore adequate ventilation, not full arousal. Over-reversal can precipitate severe, sometimes violent, withdrawal. Potent synthetics may require much higher cumulative doses of naloxone than traditional opioids. Furthermore, the duration of action of naloxone (30-90 minutes) is often shorter than that of the opioid, leading to the risk of renarcotization (recurrent respiratory depression). This necessitates a prolonged observation period and sometimes a continuous naloxone infusion.

Clonidine and Xylazine: The Alpha-2 Agonist Mimickers

Clonidine, a central alpha-2 adrenergic agonist used for ADHD and hypertension, can cause an overdose toxidrome that closely mimics opioid poisoning: CNS depression, respiratory depression, bradycardia, hypotension, and miosis. A veterinary tranquilizer, xylazine (“tranq”), works by the same mechanism and is now a common, dangerous adulterant in the illicit drug supply.

Naloxone’s Role and Xylazine’s Dangers

• Naloxone for Clonidine: While not an opioid, clonidine toxicity often responds to naloxone, which can improve CNS and respiratory depression. The mechanism is not fully understood but may involve downstream neurotransmitter pathways. Higher doses (up to 10 mg) may be needed. A mnemonic sometimes used for naloxone-responsive toxidromes is ROCK LOTA X (Reserpine, Opioids, Clonidine/alpha-2 agonists, etc).
• Xylazine (“Tranq” ): This substance causes profound sedation and hemodynamic collapse. Naloxone will reverse any co-ingested opioids but will not reverse the effects of xylazine itself. A horrifying feature of injected xylazine is the development of severe, necrotic skin ulcers and tissue destruction, likely due to intense local vasoconstriction and direct cytotoxic effects. Management is primarily supportive, with a major focus on aggressive wound care.

Acetaminophen Overdose: The Silent Liver Killer

Acetaminophen toxicity is insidious. The danger lies not with the drug itself, but its toxic metabolite, NAPQI. In an overdose, theliver’ss primary safe metabolic pathways are saturated, shunting the drug down a pathway that produces NAPQI. The liver’s natural antioxidant, glutathione, is rapidly depleted, and the unopposed NAPQI causes massive liver cell death (hepatic necrosis).

Phases and Management

The clinical course unfolds in four phases, with Phase 1 (0-24 hours) being deceptively mild (nausea, malaise). The key to management is to obtain an acetaminophen level at 4 hours post-ingestion (or as soon as possible if timing is unknown) and plot it on the Rumack-Matthew nomogram.

The antidote is N-acetylcysteine (NAC), which works by replenishing glutathione stores. It is most effective when given within 8 hours of ingestion but is still beneficial up to 24 hours. Given the mild initial symptoms, public education and a high index of clinical suspicion are crucial to prevent the progression to irreversible liver failure in Phase 3.

Aspirin (Salicylate) Toxicity: Metabolic Chaos

Salicylate toxicity is a complex metabolic emergency. Salicylates directly stimulate the brain’s respiratory center, causing an initial respiratory alkalosis. More dangerously, they uncouple oxidative phosphorylation in the mitochondria. This means the cellular machinery for energy production runs uncontrollably, generating massive amounts of heat (hyperthermia) but producing very little ATP. This leads to a profound anion gap metabolic acidosis.

Management

The classic signs are tinnitus, hyperventilation, and a mixed acid-base disorder. Management includes:

• Activated Charcoal: For recent ingestions.
• Urinary Alkalinization: An IV infusion of sodium bicarbonate is used to raise the urine pH, which “traps” the salicylate in the renal tubules and enhances its excretion. It is critical to replete potassium, as the body cannot effectively alkalinize the urine if hypokalemic.
• Hemodialysis: This is the definitive treatment for severe poisoning, indicated for very high levels, altered mental status, pulmonary edema, renal failure, or refractory acidosis.

Toxic Alcohols: Ethylene Glycol and Methanol

Ingestions of ethylene glycol (antifreeze) and methanol (windshield washer fluid) are medical emergencies. They cause a profound anion gap metabolic acidosis and an elevated osmolar gap. The parent alcohols are not the main problem; their toxic metabolites, formed by the enzyme alcohol dehydrogenase (ADH), are.

• Ethylene Glycol: Metabolized to glycolic acid (causing acidosis) and oxalic acid. Oxalic acid binds with calcium to form calcium oxalate crystals, which deposit in the renal tubules, causing acute kidney injury.
• Methanol: Metabolized to formic acid. Formic acid is a potent mitochondrial toxin that specifically targets the optic nerve, causing visual disturbances, “snowstorm” vision, and potentially permanent blindness.

Management

The cornerstone of treatment is to block ADH.

• Fomepizole: This is the preferred antidote, a potent inhibitor of ADH.
• Ethanol: If fomepizole is unavailable, a continuous IV infusion of ethanol can be used. Ethanol acts as a competitive substrate, preferentially occupying the ADH enzyme and preventing the metabolism of the more toxic alcohol.
• Hemodialysis: Dialysis is crucial to remove both the parent alcohol and the toxic metabolites, as well as to correct severe acidosis.
• Cofactors: Folate (for methanol) and thiamine/pyridoxine (for ethylene glycol) are given to help shunt metabolism down less toxic pathways.

Inhalation Injuries: Carbon Monoxide and Cyanide

In any victim of a structural fire, we must have a high index of suspicion for inhalation injuries.

Carbon Monoxide (CO) Poisoning

CO is a colorless, odorless gas that has an affinity for hemoglobin that is ~250 times greater than oxygen. It causes toxicity in two ways:

1. It binds to hemoglobin, forming carboxyhemoglobin (COHb), which reduces the blood’s oxygen-carrying capacity.
2. It causes a “left shift” in the oxyhemoglobin dissociation curve, meaning the hemoglobin that is still carrying oxygen does not release it effectively to the tissues.

The result is profound tissue hypoxia. A critical diagnostic pitfall is that standard pulse oximetry is unreliable, as it cannot distinguish between oxyhemoglobin and COHb, giving a falsely reassuring high reading. Diagnosis requires a CO-oximetry blood test to measure the COHb level.

Treatment is 100% high-flow oxygen, which dramatically reduces the half-life of COHb. Hyperbaric oxygen therapy (HBOT) may be considered for severe cases (e.g., coma, syncope, cardiac ischemia) to accelerate CO elimination further and prevent delayed neurologic sequelae.

Cyanide Poisoning

Cyanide is a product of the combustion of synthetic materials (plastics, wool, silk). It is a rapidly fatal poison that works by inhibiting cytochrome c oxidase in the mitochondria, shutting down cellular respiration and causing a profound lactic acidosis and histotoxic hypoxia (tissues cannot use the oxygen that is delivered).

The antidote of choice is hydroxocobalamin. It contains a cobalt ion that avidly binds cyanide, forming cyanocobalamin, which is simply non-toxic vitamin B12 and is readily excreted by the kidneys. This treatment is elegant and safe, as it does not compromise the blood’s oxygen-carrying capacity.

Advanced Life-Saving Therapies

High-Dose Insulin Euglycemia Therapy (HIET) and Intralipid

For severe cardiotoxicity from certain poisons, we have advanced rescue therapies.

• High-Dose Insulin Euglycemia Therapy (HIET): This has become a cornerstone for severe calcium channel blocker (CCB) and beta-blocker overdoses. In cardiogenic shock, the heart’s metabolism shifts away from its preferred fatty acids. HIET provides a massive influx of insulin (1 unit/kg bolus, then 0.5-1 unit/kg/hr infusion), which forces glucose into myocardial cells, providing a more efficient energy source. It also has direct inotropic and vasodilatory effects. This therapy requires intensive monitoring to prevent hypoglycemia (by co-administering a dextrose infusion) and hypokalemia.
• Intravenous Lipid Emulsion (ILE) Therapy: Also known as “intralipid,” this therapy is used for life-threatening toxicity from lipophilic (fat-soluble) drugs, such as local anesthetics (e.g., bupivacaine) and certain beta-blockers, CCBs, and TCAs. The lipid emulsion is thought to act as a “lipid sink,” sequestering the lipophilic drug in the intravascular space and pulling it away from its site of action in the heart and brain. It may also provide a direct energy substrate for the heart.

Other Key Antidotes and Reversal Agents

• Glucagon: For beta-blocker overdose, glucagon can bypass the blocked beta-receptor and directly activate adenylyl cyclase, increasing cAMP and improving heart rate and contractility. Its use is often limited by significant nausea and vomiting.
• Octreotide: For refractory hypoglycemia caused by sulfonylurea overdose, octreotide (a somatostatin analog) is used to shut off the pancreas’s massive insulin release.
• Protamine Sulfate: Reverses heparin.
• 4-Factor Prothrombin Complex Concentrate (PCC / Kcentra): Reverses warfarin (along with Vitamin K) and can be used off-label for DOAC-related life-threatening bleeding.
• Idarucizumab (Praxbind): Reverses dabigatran (Pradaxa).
• Andexanet alfa (Andexxa): Reverses Factor Xa inhibitors like rivaroxaban (Xarelto) and apixaban (Eliquis).
• Deferoxamine: A chelating agent for iron overdose.
• Phentolamine: An alpha-blocker injected locally to reverse tissue ischemia from vasopressor extravasation.

Post-Toxin Recovery: The Role of Integrative Chiropractic Care

The journey for a patient who has experienced an overdose or poisoning does not end upon discharge from the hospital. A toxicological insult is a profound stressor that disrupts the nervous system, overwhelms metabolic pathways, and can leave lasting deficits. This is where our integrative model, with medical oversight from Dr. Cardenas, truly shines.

• Autonomic Recalibration: Many toxic events leave the autonomic nervous system in a state of hyper-reactivity or “sympathetic overdrive.” In my practice, I have seen that gentle manual therapies, including specific chiropractic adjustments, can modulate afferent input to the central nervous system, helping to reduce sympathetic dominance and support vagal tone. This complements medical stabilization by helping to normalize heart rate variability, blood pressure, and sleep patterns (Jimenez, n.d.-b).
• Respiratory Mechanics: Following events that compromise breathing—such as organophosphate poisoning, sedative overdose, or aspiration—residual chest wall rigidity and diaphragmatic dysfunction are common. Thoracic and rib cage mobilization can improve ventilatory efficiency, reduce the work of breathing, and aid in secretion clearance.
• Pain Modulation and Musculoskeletal Recovery: Patients who have experienced severe neuromuscular irritability (e.g., from serotonin syndrome or seizures) often have significant residual muscle pain and joint dysfunction. My role as a chiropractor is to assess and treat these consequences. Through a combination of spinal adjustments, soft tissue therapies, and rehabilitative exercises, we can alleviate pain and restore normal function, often reducing the need for long-term pain medications.
• Functional and Metabolic Restoration: From a functional medicine perspective, we focus on supporting the body’s detoxification and repair mechanisms. This includes:

• Liver Support: For a patient recovering from acetaminophen toxicity, we provide nutritional building blocks for liver regeneration, such as antioxidants (glutathione, milk thistle) and nutrients that support Phase I and II detoxification pathways.
• Mitochondrial Health: For toxins that poison the mitochondria (like salicylates or cyanide), we use nutrients like Coenzyme Q10, L-carnitine, and B vitamins to support cellular energy production.
• Gut-Liver Axis: We work to restore a healthy gut microbiome, which is crucial for reducing systemic inflammation and supporting the liver’s function.

This collaboration with Dr. Cardenas is vital. She provides the medical oversight to ensure our supportive therapies are safe and appropriate, monitoring organ function and overall medical stability as the patient recovers. This teamwork ensures we are addressing the patient as a whole person—restoring their structural integrity, rebalancing their biochemistry, and supporting their body’s innate capacity to heal.

Final Takeaways and Clinical Pearls

The world of toxicology is vast, but a systematic approach grounded in a few key principles will serve you and your patients well.

• Trust Your Toxidromes: If the skin is hot and dry with mydriasis, think anticholinergic. If hot and sweaty, think sympathomimetic.
• The EKG is Key: A wide QRS with altered mental status suggests sodium channel blockade; give sodium bicarbonate immediately.
• Antidotes Have Nuances: Atropine for organophosphates is dosed to dry secretions, not to a target heart rate. NAC for acetaminophen is most effective early.
• Call for Help: The Poison Control Center (1-800-222-1222) is an invaluable, expert resource. Use it.
• Anticipate Complications: Always reassess after giving an antidote. Watch for rebound toxicity (e.g., renarcotization after naloxone wears off) or side effects of the treatment (e.g., hypoglycemia from HIET).
• Integrative Recovery Starts Early: In my clinical experience, patients who receive timely airway support, appropriate sedation, and precise antidotes recover faster. But functional recovery accelerates most when integrative support to restore autonomic and musculoskeletal balance begins early in the process, reducing the persistent tachycardia, pain amplification, and sleep disruption that can otherwise prolong rehabilitation (Jimenez, n.d.-a).

By weaving together the threads of emergency medicine, internal medicine, chiropractic, and functional medicine, we create a robust safety net for our patients. Under the expert medical direction of Dr. Maria Cardenas, our team at Injury Medical Clinic PA guides patients from the brink of an acute crisis to a state of restored health and optimized function.

References

• American Heart Association. (2020). Advanced Cardiovascular Life Support Provider Manual. American Heart Association.
• Anseeuw, K., Delvau, N., Burillo-Putze, G., De Iaco, F., Geldner, G., Holmström, P., … & Sabbe, M. (2013). Hydroxocobalamin in smoke inhalation-associated cyanide poisoning: a study from the French multicentre HUPIT database. Annals of Intensive Care, 3(1), 8.
• Barceloux, D. G., et al. (2002). American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. Journal of Toxicology: Clinical Toxicology, 40(4), 415–446.
• Borron, S. W., et al. (2007). Hydroxocobalamin for cyanide poisoning. Annals of Emergency Medicine, 49(6), 806–813.
• Boyer, E. W. (2012). Management of opioid analgesic overdose. New England Journal of Medicine, 367(2), 146–155.
• Brent, J. (2009). Fomepizole for ethylene glycol and methanol poisoning. New England Journal of Medicine, 360(21), 2216–2223.
• Brubacher, J. R., & Hoffman, R. S. (2017). Beta-Blockers and Calcium Channel Blockers. In StatPearls. StatPearls Publishing.
• Buckley, N. A., Juurlink, D. N., Isbister, G., Bennett, M. H., & Lavonas, E. J. (2011). Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database of Systematic Reviews, (4).
• Chiew, A. L., Reith, D., Pomerleau, A., & Dargan, P. I. (2020). Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand. Internal Medicine Journal, 50(2), 143-145.
• DeWitt, C. R., & Waksman, J. C. (2004). Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicology Reviews, 23(4), 223–238.
• Gummin, D. D., Mowry, J. B., Beuhler, M. C., Spyker, D. A., Bronstein, A. C., Rivers, L. J., … & Jarris, V. A. (2020). 2019 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology, 58(12), 1360-1541.
• Jimenez, A. A. (n.d.-a). Personal Injury Doctor Group.
• Jimenez, A. A. (n.d.-b). Alex Jimenez on LinkedIn.
• Juurlink, D. N., Erdman, A. R., Doyon, S., Flegel, K., Karl, P. I., & Lavergne, V. (2015). Salicylate Toxicity. In S. C. Curry, D. H. Y. Chae, & D. C. Keyes (Eds.), Tintinalli’s Emergency Medicine: A Comprehensive Study Guide (8th ed.). McGraw-Hill Education.
• Levine, M., Boyer, E. W., Pozner, C. N., & Geib, A. J. (2011). Assessment of Naloxone in Clonidine Toxicity: Case Reports and Review. Clinical Toxicology, 49(5), 396–403.
• Levine, M., et al. (2011). High-dose insulin therapy in beta-blocker and calcium channel blocker poisoning. Clinical Toxicology, 49(4), 277–283.
• McCutcheon, J. R., & Arens, A. M. (2017). Intravenous lipid emulsion therapy for drug toxicity. Journal of Medical Toxicology, 13(3), 242–251.
• Nelson, L. S., & Hoffman, R. S. (2018). Inhaled Toxins. In J. E. Tintinalli, J. S. Stapczynski, O. J. Ma, D. M. Yealy, G. D. Meckler, & D. M. Cline (Eds.), Tintinalli’s Emergency Medicine: A Comprehensive Study Guide (9th ed.). McGraw-Hill.
• Nelson, L. S., Howland, M. A., Lewin, N. A., Smith, S. W., Goldfrank, L. R., & Hoffman, R. S. (Eds.). (2019). Goldfrank’s toxicologic emergencies (11th ed.). McGraw-Hill Education.
• Piantadosi, C. A. (2008). Carbon monoxide poisoning. New England Journal of Medicine, 358(23), 2467-2475.
• Temple, A. R. (1981). Acute and chronic effects of aspirin toxicity and their treatment. Archives of Internal Medicine, 141(3), 364-369.
• Thanacoody, R., & Thomas, S. H. (2005). Methanol and ethylene glycol poisoning. Emergency Medicine Journal, 22(2), 136–138.
• S. CDC. (2023). Xylazine: An emerging threat. Centers for Disease Control and Prevention.

SEO Tags: toxicology, poison management, overdose management, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, integrative chiropractic care, functional medicine, El Paso TX, personal injury clinic, organophosphate poisoning, anticholinergic toxicity, sympathomimetic overdose, clonidine overdose, xylazine toxicity, acetaminophen overdose, salicylate toxicity, aspirin overdose, ethylene glycol poisoning, methanol poisoning, carbon monoxide poisoning, cyanide poisoning, sodium bicarbonate, naloxone, pralidoxime, atropine, N-acetylcysteine, intralipid therapy, high-dose insulin euglycemia therapy, HIET, activated charcoal, whole bowel irrigation, hemodialysis, beta-blocker overdose, calcium channel blocker overdose, serotonin syndrome, anticoagulant reversal, Toxidromes, flumazenil, octreotide, phentolamine, rehabilitation